Harmony Biosciences Inc.
(HRMY)
undefined
undefined%
At close: undefined
32.39
0.03%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 582.02M | 437.86M | 305.44M | 159.74M | 6.00M | - |
Cost of Revenue | 121.24M | 83.48M | 55.52M | 27.74M | 1.58M | 184.00K |
Gross Profit | 460.79M | 354.37M | 249.92M | 132.00M | 4.42M | -184.00K |
Operating Income | 192.03M | 120.19M | 68.70M | 3.68M | -145.90M | -41.44M |
Interest Income | 14.73M | 3.13M | 223.00K | 28.22M | 6.07M | - |
Pretax Income | 173.40M | 104.69M | 37.43M | -36.94M | -151.98M | -39.90M |
Net Income | 128.85M | 181.47M | 34.60M | -51.86M | -158.05M | -39.90M |
Selling & General & Admin | 192.69M | 163.30M | 132.03M | 95.57M | 80.73M | 29.07M |
Research & Development | 76.06M | 70.89M | 30.37M | 19.45M | 69.59M | 12.37M |
Other Expenses | - | 169.00K | 16.00K | -3.07M | - | - |
Operating Expenses | 268.76M | 234.19M | 162.39M | 115.02M | 150.32M | 41.44M |
Interest Expense | 23.76M | 15.67M | 23.97M | 28.22M | 6.07M | - |
Selling & Marketing Expenses | 97.40M | 79.28M | 68.12M | 55.82M | 44.32M | 16.86M |
Cost & Expenses | 389.99M | 317.67M | 217.91M | 142.76M | 151.90M | 41.44M |
Income Tax | 44.54M | -76.78M | 2.83M | 14.91M | 6.07M | 1.54M |
Shares Outstanding (Basic) | 59.47M | 59.17M | 57.53M | 56.89M | 63.68M | 49.24M |
Shares Outstanding (Diluted) | 60.37M | 61.10M | 59.21M | 56.89M | 63.68M | 49.24M |
EPS (Basic) | 2.17 | 3.07 | 0.60 | -0.91 | -2.48 | -0.81 |
EPS (Diluted) | 2.13 | 2.97 | 0.58 | -0.91 | -2.48 | -0.81 |
EBITDA | 221.51M | 143.57M | 106.37M | 1.51M | -142.69M | -41.26M |
Depreciation & Amortization | 24.36M | 23.39M | 18.84M | 10.24M | 3.21M | 184.00K |